Unraveling New Mechanisms in Itch from Targeting Type 2 Inflammation

Time: 9:00 am
day: Day One

Details:

  • Understanding shared and unique characteristics of AD, PN and CSU
  • How type 2 inflammation contributes to neuroimmune dysregulation 
  • Potential for IL-4Ra antagonism to reduce itch in chronic inflammatory skin diseases.

Speakers: